Drug Approvals
🇺🇸 FDA Page 40FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 469–480 of 665 articles
Makary Resigns as FDA Commissioner: Implications for Drug Approvals
Amgen Inc Stock: Lung Cancer Setback Meets Steady Cash Flow
Four FDA Actions Reshaping Drug Development in 2026
FDA Policy Tracker 2026: Psychedelics Regulatory Updates
6 Biotechs That Could Be Big Pharma’s Next M&A Target
FDA Grants Dual Approval for T-DXd in HER2+ Early Breast Cancer
FDA Blocks Melanoma Drug Amid Confusion Under Makary Leadership
FDA Roundup: Oncology Drug Approvals in 2026
NICE Backs Imfinzi for Stomach Cancer: Implications for Investors
WHO Declares Ebola Outbreak an International Emergency
Novel Drug Approvals for 2026: Insights from the FDA
DIA 2024: What to Expect at the Regulatory Conference